摘要
随着肾脏替代治疗技术的逐渐成熟,延长寿命及提高生活质量已经成为管理尿毒症患者的最终目标。近年来国内外多项研究提示,低镁血症可影响透析患者的预后,可能与死亡风险增加相关。我们从机制上了解血镁与血压、心血管疾病、骨代谢、血管钙化的相关性,指出血镁可能成为降低透析患者病死率的管控指标之一,挖掘其新的临床应用。
With the gradual maturity of renal replacement therapy technology,prolonging life span and improving quality of life of patients with uremia have become the ultimate management goals.In recent years,many studies at home and abroad have suggested that hypomagnesemia has an adverse effect on the prognosis of dialysis patients,which may be related to an increased risk of death.We understand the correlation between blood magnesium and blood pressure,cardiovascular disease,bone metabolism and vascular calcification,point out that blood magnesium may become one of the control indicators to reduce the mortality of dialysis patients,and explore its new clinical application.
作者
罗丽君
石咏军
李幼奇
Luo Lijun;Shi Yongjun;Li Youqi(Department of Nephrology,Affiliated Huidong Hospital of Guangdong Medical University,Huizhou 516300,China;Department of Nephrology,Affiliated Huizhou Hospital of Guangdong Medical University,Huizhou 516000,China)
出处
《中国综合临床》
2022年第2期188-192,共5页
Clinical Medicine of China
关键词
血镁
尿毒症
血液透析
腹膜透析
生存预后
Blood magnesium
Uremia
Hemodialysis
Peritoneal dialysis
Survival prognosis